# Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD

> **NCT05408897** · — · RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 45 (estimated)

## Conditions studied

- Gastrointestinal Stromal Tumors
- Minimal Residual Disease

## Interventions

- **DIAGNOSTIC_TEST:** liquid biopsy

## Key facts

- **NCT ID:** NCT05408897
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-01
- **Primary completion:** 2023-04
- **Final completion:** 2028-04
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2022-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05408897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05408897, "Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05408897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*